网站综合信息 www.mmv.org
    • 标题:
    • Medicines for Malaria Venture | Develo 
    • 关键字:
    •  
    • 描述:
    • MMV is a nonprofit foundation created to discover, develop and deliver new, affordable antimalarial  
    • 域名信息
    • 域名年龄:24年8个月23天  注册日期:2000年02月09日  到期时间:
      邮箱:adrienne31  电话:+41.225550301
      注册商:GoDaddy.com, LLC (R91-LROR) 
    • 服务器空间
    • IP:74.207.233.110 同IP网站2个 详情
      地址:美国 佐治亚州亚特兰大市Linode公司
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 百度
    • 0  
    • 0  
    • 快照:无首页快照  
    • Google
    • 3,420  
    • 162  
    • pr:6  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 50  
    •  
    • 评级:3/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • 1,082,918  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • 258 
    • dmoz目录收录
    • Health/Conditions_and_Diseases/Infectious_Diseases/Parasitic/Malaria/Research  

    • 流量走势图
    域名注册Whois信息

    mmv.org

    域名年龄: 24年8个月23天
    注册时间: 2000-02-09
    注 册 商: GoDaddy.com, LLC (R91-LROR)
    注册邮箱: adrienne31
    联系电话: +41.225550301

    获取时间: 2015年04月11日 14:30:21
    Domain Name:MMV.ORG
    Domain ID: D19464296-LROR
    Creation Date: 2000-02-09T08:51:32Z
    Updated Date: 2012-11-29T09:49:46Z
    Registry Expiry Date: 2019-02-09T08:51:32Z
    Sponsoring Registrar:GoDaddy.com, LLC (R91-LROR)
    Sponsoring Registrar IANA ID: 146
    WHOIS Server:
    Referral URL:
    Domain Status: clientDeleteProhibited -- http://www.icann.org/epp#clientDeleteProhibited
    Domain Status: clientRenewProhibited -- http://www.icann.org/epp#clientRenewProhibited
    Domain Status: clientTransferProhibited -- http://www.icann.org/epp#clientTransferProhibited
    Domain Status: clientUpdateProhibited -- http://www.icann.org/epp#clientUpdateProhibited
    Registrant ID:CR130365992
    Registrant Name:Adrienne MacDonald
    Registrant Organization:Medicines for Malaria Venture
    Registrant Street: Route de Pre-Bois 20
    Registrant City:Geneva
    Registrant State/Province:
    Registrant Postal Code:1215
    Registrant Country:CH
    Registrant Phone:+41.225550301
    Registrant Phone Ext:
    Registrant Fax:
    Registrant Fax Ext:
    Registrant Email:adrienne31
    Admin ID:CR130365996
    Admin Name:Adrienne MacDonald
    Admin Organization:Medicines for Malaria Venture
    Admin Street: Route de Pre-Bois 20
    Admin City:Geneva
    Admin State/Province:
    Admin Postal Code:1215
    Admin Country:CH
    Admin Phone:+41.225550301
    Admin Phone Ext:
    Admin Fax:
    Admin Fax Ext:
    Admin Email:adrienne31
    Tech ID:CR130365994
    Tech Name:Adrienne MacDonald
    Tech Organization:Medicines for Malaria Venture
    Tech Street: Route de Pre-Bois 20
    Tech City:Geneva
    Tech State/Province:
    Tech Postal Code:1215
    Tech Country:CH
    Tech Phone:+41.225550301
    Tech Phone Ext:
    Tech Fax:
    Tech Fax Ext:
    Tech Email:adrienne31
    Name Server:NS43.DOMAINCONTROL.COM
    Name Server:NS44.DOMAINCONTROL.COM
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    DNSSEC:Unsigned

    Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to(a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy. For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.
    同IP网站(同服务器)
  • 74.207.233.110 共2个网站 (美国 佐治亚州亚特兰大市Linode公司)
  • Medicines for Malaria Ve
  • Medicines for Malaria Ve
  • 其他后缀域名
    • 顶级域名
    • 相关信息
    • mmv.cn
    • 已注册 2005年04月14日
    网站首页快照(纯文字版)
    抓取时间:2019年06月10日 04:47:17
    网址:http://www.mmv.org/
    标题:Medicines for Malaria Venture | Developing antimalarials to
    关键字:
    描述:MMV is a nonprofit foundation created to discover, develop and deliver new, affordable antimalarial drugs through effective public-private partnerships.
    主体:
    Skip to main contentENGFRENGFRSearch formSearchMedicines for Malaria VentureDeveloping antimalarials to save livesResearch & DevelopmentMMV-supported projectsR&D areas of workNext-generation medicinesScience of eradicationProducts for vulnerable populationsWorking with regulatorsInformation for scientistsCall for proposalsTPPs & TCPsProject of the year awardComputational chemistryGlobal health compound design webinarsR&D challengesAccessProducts & projectsAreas of workSupporting introductionEnhancing reachInforming R&DGathering market intelligenceProduct mapsASAQ Winthrop® mapASMQ mapArtesun® mapCoartem® Dispersible mapEurartesim® mapKozenis/Krintafel mapPyramax® mapPyramax® granules mapRectal artesunate mapSPAQ mapTool KitsInjectable artesunate tool kitRectal artesunate tool kitSeasonal Malaria Chemoprevention Tool KitThe road to health impactAccess challengesPartneringOur partner networkThe PDP modelSocially responsible agreementsOur clinical centre partnersOur donorsCurrent donorsPast donorsDonate to MMVDonor storiesOur impactAchievementsReal life storiesImpact of the global malaria communityAbout usWhat we doAn overview of our workOur strategic focusOur historyPeople & governanceStaff biosStaff mapStaff interviewsBoard of DirectorsMMV North America BoardExpert Scientific Advisory CommitteeAccess & Product Management Advisory CommitteeGlobal Safety BoardWork with usJobsRFPs/RFIsMMV's internship programmePoliciesFunding and expenditureFAQsContact usMalaria & medicinesDefinitions and symptomsFive speciesParasite lifecycleMalaria facts & figuresMalaria treatmentHistory of antimalarialsOptimizing artemisinin productionMalaria online courseNewsroomNews & Press ReleasesFilmsInfographicsInterviewsImage slideshowsPublicationsAudioEventsMMV OpenPandemic Response BoxAbout the Pandemic Response BoxRequest the Pandemic Response BoxSupporting informationTerms & conditionsPathogen BoxAbout the Pathogen BoxRequest the Pathogen BoxExploiting the Pathogen BoxPathogen Box researchSupporting informationTerms & conditionsMalaria BoxAbout the Malaria BoxMalaria Box ResearchSupporting informationTerms & conditionsMap of box ordersFollow-up guidelinesOpen Source Drug DiscoveryMMV Open TeamContact usMMV's 20th Anniversary11 November 2019Igniting drug discovery for pandemic preparednessRecovering from severe malaria — Desmond's storyPhoto: Damien Schumann    Photo: Damien SchumannAchievements.    Over 230    Pathogen Boxesshipped free of charge to scientists around the world to boost drug discovery for neglected diseases.    18,000    health-care workersacross 2,082 health-care facilities trained to administer injectable artesunate for severe malaria.    Single-dose    tafenoquinefor relapse prevention of P. vivax malaria approved by the US FDAHomeNewsMAMaZ against Malaria at Scale set to benefit four times more people at risk of malaria in rural ZambiaLife-saving malaria project in Zambia to expand    25 Apr 2019    Press releaseInventor of MMV compounds OZ277 and OZ

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2024-10-23 10:39, Process in 0.0061 second.